Malignant progression to anaplastic meningioma: Neuropathology, molecular pathology, and experimental models.
Cimino PJ.
Exp Mol Pathol. 2015 Oct;99(2):354-9. doi: 10.1016/j.yexmp.2015.08.007. Epub 2015 Aug 22.
Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas.
Maggio I, Franceschi E, Tosoni A, Nunno VD, Gatto L, Lodi R, Brandes AA.
CNS Oncol. 2021 Jun 1;10(2):CNS72. doi: 10.2217/cns-2021-0003. Epub 2021 May 21.
Meningioma.
Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E, Vecht C.
Crit Rev Oncol Hematol. 2008 Aug;67(2):153-71. doi: 10.1016/j.critrevonc.2008.01.010. Epub 2008 Mar 14.
An overview of meningiomas.
Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV.
Future Oncol. 2018 Sep;14(21):2161-2177. doi: 10.2217/fon-2018-0006. Epub 2018 Aug 7.
Malignant meningiomas.
Fountain DM, Young AMH, Santarius T.
Handb Clin Neurol. 2020;170:245-250. doi: 10.1016/B978-0-12-822198-3.00044-6.
A clinically applicable integrative molecular classification of meningiomas.
Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R, Macklin AM, Khan S, Singh O, Karimi S, Corona RI, Liu LY, Chen CY, Chakravarthy A, Wei Q, Mehani B, Suppiah S, Gao A, Workewych AM, Tabatabai G, Boutros PC, Bader GD, de Carvalho DD, Kislinger T, Aldape K, Zadeh G.
Nature. 2021 Sep;597(7874):119-125. doi: 10.1038/s41586-021-03850-3. Epub 2021 Aug 25.
Late malignant transformation of anaplastic meningioma 18 years after primary surgery: A case report.
Fujii Y, Ogiwara T, Yamazaki D, Hanaoka Y, Horiuchi T.
J Clin Neurosci. 2021 Apr;86:136-138. doi: 10.1016/j.jocn.2021.01.027. Epub 2021 Feb 5.
Atypical meningiomas.
Chen R, Aghi MK.
Handb Clin Neurol. 2020;170:233-244. doi: 10.1016/B978-0-12-822198-3.00043-4.
[Anaplastic (malignant) meningioma].
Hirano H.
Ryoikibetsu Shokogun Shirizu. 2000;(28 Pt 3):139-41.
Histopathology of Meningiomas.
Raghunathan A, Giannini C.
Adv Exp Med Biol. 2023;1416:35-45. doi: 10.1007/978-3-031-29750-2_4.
